These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2433684)

  • 21. Occult axillary lymph node metastases discovered by serial section in node-negative breast cancer.
    Karalak A; Homcha-Em P
    J Med Assoc Thai; 1999 Oct; 82(10):1017-9. PubMed ID: 10561965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histoenzymological and ultrastructural changes of axillary lymph nodes with breast cancer metastases.
    Bârsu M; Cotuţiu G; Dobrescu G; Carasevici E; Stoica L
    Morphol Embryol (Bucur); 1982; 28(4):299-302. PubMed ID: 6218399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ; House D
    Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Huygelen V; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    Br J Cancer; 2006 Nov; 95(10):1362-6. PubMed ID: 17088912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The prognostic significance of axillary node metastasis in breast cancer].
    Miura S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():36-42. PubMed ID: 8702309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer.
    Seenu V; Pavan Kumar MN; Sharma U; Gupta SD; Mehta SN; Jagannathan NR
    Magn Reson Imaging; 2005 Dec; 23(10):1005-10. PubMed ID: 16376185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
    Chen Z; Lu X; Huang R
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Various aspects of the relationship between breast cancer and axillary lymph nodes].
    Bălan R
    Morphol Embryol (Bucur); 1976; 22(4):275-80. PubMed ID: 136598
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer.
    Raymond WA; Leong AS
    Pathology; 1989 Jan; 21(1):11-5. PubMed ID: 2474791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of monoclonal antibody anticytokeratins for detecting lymph node micrometastases from breast carcinoma.
    Pelosi G
    Arch Pathol Lab Med; 1990 May; 114(5):450-1. PubMed ID: 1692201
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunohistochemical investigation of axillary lymph nodes for micrometastases in patients with breast cancer using E29.
    Cavaliere A; Falini B; Antonini G
    Tumori; 1989 Dec; 75(6):563-5. PubMed ID: 2617701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical detection of progesterone receptors in breast cancer. Comparison of antibodies mPRI and PR-ICA].
    Weikel W; Rosenthal H; Beck T; Mitze M
    Pathologe; 1990 Mar; 11(2):85-8. PubMed ID: 2184428
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast.
    Bussolati G; Gugliotta P; Morra I; Pietribiasi F; Berardengo E
    Br J Cancer; 1986 Oct; 54(4):631-6. PubMed ID: 3535864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymph node metastasis in lobular breast cancer--an immunohistochemical study].
    Lee A; Kainz C; Danihel L; Gitsch G; Dadak C; Breitenecker G
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():107. PubMed ID: 1283707
    [No Abstract]   [Full Text] [Related]  

  • 40. [Leptomeningeal carcinosis--new diagnostic possibilities by tumor cell marking with monoclonal antibodies].
    Pfadenhauer K; Schlimok G
    Nervenarzt; 1990 Apr; 61(4):228-30. PubMed ID: 1693754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.